In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 13-944V
Filed: July 15, 2016
* * * * * * * * * * * * * * * * UNPUBLISHED
DOROTHY ARCHIBONG, *
* Special Master Hamilton-Fieldman
Petitioner, *
* Attorneys’ Fees and Costs;
v. * Reasonable Amount Requested to
* which Respondent Does Not Object.
SECRETARY OF HEALTH *
AND HUMAN SERVICES, *
*
Respondent. *
* * * * * * * * * * * * * * * *
Martin Jeffrey Rubenstein, Staten Island, NY, for Petitioner.
Gordon Elliot Shemin, United States Department of Justice, Washington, D.C., for Respondent.
DECISION 1
On December 2, 2013, Dorothy Archibong (“Petitioner”) filed a petition for
compensation pursuant to the National Vaccine Injury Compensation Program. 2 42 U.S.C. §§
300aa-1 to -34 (2006). Petitioner alleged that a Tetanus-Diphtheria-acellular-Pertussis (“TDaP”)
vaccine administered on February 15, 2011 caused her to suffer from Guillain-Barré syndrome
(“GBS”), demyelinating disease, and chronic inflammatory demyelinating polyneuropathy
(“CIDP”). On April 14, 2016, the undersigned issued a decision awarding compensation to
Petitioner. Judgment entered on the decision on May 3, 2016.
1
Because this decision contains a reasoned explanation for the undersigned’s action in this case, the
undersigned intends to post this ruling on the website of the United States Court of Federal Claims, in
accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913
(codified as amended at 44 U.S.C. § 3501 note (2012)). As provided by Vaccine Rule 18(b), each party
has 14 days within which to request redaction “of any information furnished by that party: (1) that is a
trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes
medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of
privacy.” Vaccine Rule 18(b).
2
The National Vaccine Injury Compensation Program is set forth in Part 2 of the National
Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended,
42 U.S.C. §§ 300aa-1 to -34 (2006) (Vaccine Act or the Act). All citations in this decision to
individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.
1
On June 20, 2016, Petitioner filed a timely motion for attorneys’ fees and costs
(“Motion”). 3 Petitioner seeks compensation for attorneys’ costs in the amount of $7,139.94 and
for attorneys’ fees in the amount of $31,950.00. Petitioner and her counsel have verified that
Petitioner did not personally incur any costs in pursuit of her claim. See General Order #9
Statement, filed June 30, 2016.
On July 14, 2016, Respondent filed a Response to Petitioner’s Motion in which she states
that she “does not object to the overall amount sought, as it is not an unreasonable amount to
have incurred for proceedings in this case to date.”
The Vaccine Act permits an award of reasonable attorneys’ fees and costs. 42 U.S.C.
§ 300aa-15(e). The undersigned finds that this petition was brought in good faith and that there
existed a reasonable basis for the claim. Therefore, an award for fees and costs is appropriate,
pursuant to 42 U.S.C. § 300aa-15(b) and (e)(1). Further, the proposed amounts seem reasonable
and appropriate. Accordingly, the undersigned hereby awards the amount of $39,089.94, in
the form of a check made payable jointly to Petitioner and Petitioner’s counsel, Martin
Jeffrey Rubenstein.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court shall enter judgment in accordance herewith. 4
IT IS SO ORDERED.
s/ Lisa Hamilton-Fieldman
Lisa Hamilton-Fieldman
Special Master
3
Pursuant to Vaccine Rule 13(a), any request for attorneys’ and costs must be filed no later than 180 days
after the entry of judgment.
4
Entry of judgment can be expedited by each party’s filing of a notice renouncing the right to seek
review. Vaccine Rule 11(a).
2